1 / 19

Disclosure

R1 Re- engineering the drug preparation - the Swedish model Dr Eva Sjökvist Saers APL Apotek Produktion & Laboratorier AB Sweden. Disclosure. Eva Sjökvist Saers, CEO of APL Apotek Produktion & Laboratorier AB

janef
Download Presentation

Disclosure

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. R1 Re-engineering the drug preparation- the Swedish modelDr Eva Sjökvist SaersAPLApotek Produktion & Laboratorier ABSweden

  2. Disclosure Eva SjökvistSaers, CEO of APL ApotekProduktion & LaboratorierAB • APL is a state-owned company and a national centre of excellence for compounded pharmaceuticals. • APL is a “extempore pharmacy”, with license from MPA, that offers compounding services (development and manufacturing of extemporaneous preparations and stock preparations) to community and hospital pharmacies, either directly according to agreements as a part of the hospital pharmacy or as a subcontractor. • APL offers its services according to equal and non-discriminating conditions, as an assignment from the government. • The compounding sector is today on a competitive market • APL is also a CDMO (Contract Development and Manufacturing Organisation) that offers development and manufacturing services to companies within Life Science.

  3. To move from onemodeltoanotherRe-regulationof the pharmacy market in Sweden – consequences on the hospital pharmacieswith focus on compounding

  4. Earliermodel Re-regulationof the pharmacy market in Sweden – consequences on the hospital pharmacies • Until 2009/2010 the state-ownedcompany Apoteket hadthe exclusive right toselldrugs in Sweden – community and hospital pharmacies • All hospital pharmacieswererun by Apoteket, on behalfofeachcounty council accordingtoagreements. • Preparations ofcytotoxics and sterile individual preparations weremade at the hospital pharmacies • Compounding(extemporaneous preparations, stock preparations) was centralised to the fourproductionunitsofAPL (earliersubsidiaryto Apoteket) • Onenational process owner for the ”manufacturing/compounding process” at Apoteket/APL

  5. Earliermodel Developmentofcompounding -earliermodel • The process ownerof the manufacturing/compounding process waschairmanof a ”manufacturing forum” • Holistic viewofactivitiesongoing at the hospital pharmacies, with a focus on compounding • Local and national initiatives – joint activities • Topicse.g.- qualityassurance/patient safety- workingenvironment/ergonomics- harmonisation/standardisation/efficiency- IS/IT- communication/collaborationswithhealthcare- dosebanding- automation

  6. APL’sextemporaneouspharmaceuticals • > 10.000 compositions in data base • ~ 2.000 compositions manufactured frequently • About 300 stock preparations, of which 140 with a national license from MPA • Therapeutic areas e.g.: • Pediatrics • Pain • Dermatology • Dental care • Cardiovascular • Stomach/intestine • Eyes/ear • Gynecology • Urology • Veterinary

  7. Non-sterileSemi-solids Ointments /creams Gels Lotions Suspensions Liquids Oral solutions Emulsions Suspensions Solid preparations Capsules Extemporaneous pharmaceuticals – dosage forms by APL Aseptic/Sterile • Parenteral preparations • Vials • Bottles • Ampoules • Bags • Eye/Ear preparations • Drops • Ointment • Gels • Ambulatory systems EAHP 2014 - Eva Sjökvist Saers, Sweden

  8. APL largescalemanufacturingof stock preparationsand extemporaneousmanufacturing Umeå Sterile and asepticmanufacturing Clinical trials materials Göteborg Non-sterile manufacturing Oral solutions SupplyChain & LogisticsExtemporaneouspharmaceuticals Stockholm Solid preparations Clinical trials materials Pharmaceutical/AnalyticaldevelopmentAPL Customer Services Extemporaneouspharmaceuticals Malmö Non-sterile manufacturing Semi solids Preparation at hospitals (tender) West Sweden: Varberg, Sahlgrenska, Östra, Uddevalla, Skövde, Borås Stockholm: Solna and Stockholm

  9. Developmentofindividualisedmedicines for patients with special needs APL Customer Services Product range specialist Formulation specialist Procurement/Logistics Medical Products Agency (MPA) Extemporaneous preparations/Stock preparationsSupply Individualisedmedicines EAHP 2014 - Eva Sjökvist Saers, Sweden

  10. Currentmodel Health care at hospitals in Sweden • At the regional level, responsibility for financing and providing health care is decentralized to the county councils (regions). • 21 regions areresponsible for the organisation and management ofhealthcare at the hospitals in eachregion • Hospital pharmacy management – procurement process withstrictrequirements. The requirementsare set by the respective regions. • Onlyone region manages the hospital pharmaciesin-house (Jönköping) Stockholm Gothenburg Malmö

  11. Currentmodel Contracted services

  12. Currentmodel Procurement process of hospital pharmacyactivities • Accordingto the law on public procurement • Strictrequirements- all mandatory and needto be fulfilled by the provider • Providers present tender withtheir suggestions on howtoprovide the services • The decision is announced • The decision can be appealedagainst by the contractor/s whodid not win the procurement • The lengthof the contractvaries - e.g. 3+2, 4+2, 6+4 years Balancebetween quality and cost

  13. Requirementspecifications(no of mandatory claims)Tender in Stockholm county council for extemporaneousmanufacturing • Supplyreliability (3) • Openinghours and avaliability (7) • Monitoring (4) • Principles for pricing (8) • Clinical trial materials (5) • Environmentalissues (2) • Performance (14) • Approx. 190 mandatory claims • Tender invitation (general claims 34) • Assignment (4) • Organisation (23) • Quality management (11) • Supplyofgoods (22) • Ordering process (29) • Distribution (23)

  14. Contractors to date * extempore pharmacy ** pharmacychainwithcommunity and hospital pharm.

  15. Increased focus on optimal drugutilisation and patient safety in the countycouncils • Increasedcompetence • Experience from hospital pharmacy management • Moreinitiatedprocurersof services • Some services performed in-house • Innovation in partnership Pharmacistsemployed by the countycouncils Number Year

  16. Forum for national developmentofactivities at hospital pharmaciesincl. extemporaneous preparations • Swedish SocietyofPharmaceuticalsciences - Swedish Societyof Hospital Pharmacy Section for members from e.g. hospital pharmacies, countycouncils, authorities • Swedish Association ofLocalAuthorities and Regions Workinggroup for pharmacistsemployed by the countycouncils

  17. Someconsequencesof the currentmodel • Fragmentationwith less overview • Regional aspectsratherthan national • Costcuttingcanleadto less time for continoustraining/educationofstaff • Competitionleadsto less opennessbetweenplayers • Competition and diversity drive innovation • Competitionlowers the price • A varietyof services and solutions available from different providers • Someissuesbecomemoresignificant (IT, logistics etc)

  18. Thanksto Lars-Åke SöderlundSwedish SocietyofPharmaceuticalsciences (board) /Apoteket Sari Frigård Swedish Societyof Hospital Pharmacy (chairman) / Apoteket Magnus Munge Swedish Societyof Hospital Pharmacy(board) / County council of Kronoberg Eva Einarsson Apotek Hjärtat Business unit Health care

  19. eva.sjokvistsaers@apl.se Thankyou! Together we contribute to drugsthat improve and save lives!We are proud of that!

More Related